Clinical trial uses prime editing to alter DNA directly in a patient
Nature reported that a clinical trial used CRISPR prime editing to alter DNA directly inside a person for the first time.
A clinical trial has used CRISPR prime editing to alter DNA directly in a person's body, Nature reported. The treatment is being tested for a genetic disease that can affect the liver and nervous system.
The report describes an early clinical application of the precision gene-editing technique; its safety and effectiveness will require continued trial results.